Philips Foundation has released its 2025 Annual Report, highlighting a successful year in which it enabled access to healthcare for 69 million people in underserved communities, while focusing on scaling proven healthcare models. The progress brings Philips Foundation closer to its ambition of reaching 100 million people annually by 2030.
In 2025, Philips Foundation sharpened its approach to catalytic philanthropy by concentrating resources on healthcare solutions with stronger evidence, operational readiness and clear system fit in two priority areas: cardiovascular disease and maternal and child health, a press release stated. Its continuum-of-capital model uses grants to test and validate approaches in underserved settings, and impact investments and co-investment to help proven solutions scale.
“In order to improve healthcare access in a sustainable way, Philips Foundation is focusing on supporting solutions that will strengthen the chain of care from prevention to treatment, to create more reliable and resilient healthcare systems for underserved communities,” said Marnix van Ginneken, chief ESG and legal officer of Philips and chair of the Board of the Philips Foundation.
A focus on building lasting change
In cardiovascular disease, Philips Foundation is supporting approaches that connect prevention, early risk detection, diagnosis and referral. Only recently, Philips Foundation and Novartis Foundation announced a global partnership to expand the CARDIO4Cities approach, starting in Amsterdam, with potential future expansion to other cities and urban regions. The partnership focuses on data-driven, locally led action to improve cardiovascular health and reduce health inequities in cities.
When it comes to maternal and child health, Philips Foundation is supporting scalable models that strengthen the chain of care, by focusing for example on reproductive health. A concrete example is 28X, a menstrual cycle tracking tool launched in 2026 in the UK, in which Philips Foundation invested through its impact investment subsidiary to reach women often left behind by traditional health innovation. Designed to work in real-world conditions, 28X helps women better understand their bodies, track patterns and recognize symptoms early, without needing specialist support.
Philips Foundation also launched ImpactBridge in 2025 with the World Diabetes Foundation and We Share Forward Foundation, a co-investment platform that connects social ventures with aligned capital and sector expertise to accelerate the transition from proof to scale.
